Aromatic xanthates and dithiocarbamates were used as chain‐transfer agents (CTAs) in reversible addition–fragmentation chain‐transfer (RAFT) polymerizations of ethylene under milder conditions (≤80 °C, ≤200 bar). While detrimental side fragmentation of the intermediate radical leading to loss of living chain‐ends was observed before with alkyl xanthate CTAs, this was absent for the aromatic CTAs. The loss of living chain‐ends was nevertheless detected for the aromatic xanthates via a different mechanism based on cross‐termination. Narrow molar‐mass distributions with dispersities between 1.2 and 1.3 were still obtained up to number average molar masses Mn of 1000 g mol−1. The loss of chain‐ends was minor for dithiocarbamates, yielding polyethylene up to Mn=3000 g mol−1 with dispersities between 1.4 and 1.8. While systems investigated showed significant rate retardation, the dithiocarbamates are the first CTAs giving polyethylene with a high livingness via RAFT polymerization.
Poly(ethylene oxide) (PEO) with dithiocarbamate chain ends (PEO–SC(=S)−N(CH3)Ph and PEO–SC(=S)−NPh2, named PEO‐1 and PEO‐2, respectively) were used as macromolecular chain‐transfer agents (macro‐CTAs) to mediate the reversible addition–fragmentation chain transfer (RAFT) polymerization of ethylene in dimethyl carbonate (DMC) under relatively mild conditions (80 °C, 80 bar). While only a slow consumption of PEO‐1 was observed, the rapid consumption of PEO‐2 led to a clean chain extension and the formation of a polyethylene (PE) segment. Upon polymerization, the resulting block copolymers PEO‐b‐PE self‐assembled into nanometric objects according to a polymerization‐induced self‐assembly (PISA).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.